Press Release RSS Feed (opens in new window)

Press Releases

Press release year list 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007
December 22, 2025
Novocure to Present at 44th Annual J.P. Morgan Healthcare Conference
December 1, 2025
Novocure Appoints Company President Frank Leonard as Chief Executive Officer
November 26, 2025
Novocure to Participate in 37th Annual Piper Sandler Healthcare Conference
November 12, 2025
Novocure to Participate in 2025 Jefferies Global Healthcare Conference
October 30, 2025
Novocure Reports Third Quarter 2025 Financial Results
October 15, 2025
Novocure to Present New Research for Tumor Treating Fields (TTFields) Therapy at European Association of Neuro-Oncology (EANO) Meeting and the European Society for Medical Oncology (ESMO) Congress
October 1, 2025
Novocure to Report Third Quarter 2025 Financial Results
September 29, 2025
Novocure to Present Final Results from the Pivotal Phase 3 METIS Trial of its Tumor Treating Fields (TTFields) Therapy for Brain Metastases from Non-Small Cell Lung Cancer at 2025 ASTRO Annual Meeting
September 15, 2025
Novocure’s Optune Lua® Receives Approval in Japan for the Treatment of Unresectable Advanced/Recurrent Non-Small Cell Lung Cancer (NSCLC)
August 28, 2025
Novocure Announces Upcoming Investor Events
August 25, 2025
Novocure Announces Coverage of Tumor Treating Fields (TTFields) Therapy for Patients with Newly Diagnosed Glioblastoma in Spain
August 20, 2025
Novocure Submits Premarket Approval Application to FDA for Tumor Treating Fields Therapy in Locally Advanced Pancreatic Cancer
July 24, 2025
Novocure Reports Second Quarter 2025 Financial Results
July 1, 2025
Novocure to Present Final Secondary Endpoint Data from the Phase 3 PANOVA-3 Trial of Tumor Treating Fields (TTFields) in Pancreatic Cancer at the ESMO Gastrointestinal Cancers Congress 2025
June 30, 2025
Novocure to Report Second Quarter 2025 Financial Results
May 31, 2025
Results From the Phase 3 PANOVA-3 Trial of Novocure’s Tumor Treating Fields (TTFields) Therapy for Pancreatic Cancer to be Presented at 2025 ASCO Annual Meeting
May 27, 2025
Novocure Announces Upcoming Investor Events
April 24, 2025
Novocure Reports First Quarter 2025 Financial Results
April 23, 2025
Novocure to Present Results from the Phase 3 PANOVA-3 Clinical Trial of its Tumor Treating Fields (TTFields) Therapy for Pancreatic Cancer as a Late-Breaking Oral Presentation at the 2025 ASCO Annual Meeting
April 22, 2025
Novocure’s Optune Lua® Receives CE Mark Approval for the Treatment of Metastatic Non-Small Cell Lung Cancer
April 1, 2025
Novocure to Report First Quarter 2025 Financial Results
March 4, 2025
Novocure to Participate in Leerink Partners 2025 Global Healthcare Conference
February 27, 2025
Novocure Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Company Update
January 22, 2025
Novocure Inaugurates New Global Headquarters in Canton of Zug, Switzerland
January 13, 2025
Novocure Announces Preliminary Full Year and Fourth Quarter 2024 Performance and Provides Company Update
January 3, 2025
Novocure to Participate in 43rd Annual J.P. Morgan Healthcare Conference